BCAL
BDX.AXBCAL Diagnostics Limited Price (BDX.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
246,225,497
(16.7484)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
BCAL Diagnostics LimitedCurrency: AUD
| YEAR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
242,288.00
+0% |
258,243.00
+7% |
442,096.00
+71% |
275,252.00
-38% |
718,669.00
+161% |
2,852,694.00
+297% |
3,098,099.00
+9% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 14,040.00 | 3,552.00 | 7,727.00 | 0.00 | 20,607.00 | 113,615.00 | 0.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
228,248.00
+0% |
254,691.00
+12% |
434,369.00
+71% |
275,252.00
-37% |
698,062.00
+154% |
2,739,079.00
+292% |
3,098,099.00
+13% |
||||||||||||
| Gross Profit Ratio | (0.94%) | (0.99%) | (0.98%) | (1.00%) | (0.97%) | (0.96%) | (1.00%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 251,901.00 | 205,385.00 | 466,773.00 | 664,113.00 | 1,124,347.00 | 3,234,514.00 | 4,361,091.00 | ||||||||||||
| General and Administrative | 144,278.00 | 136,913.00 | 176,853.00 | 249,038.00 | 1,869,673.00 | 2,350,116.00 | 1,642,575.00 | ||||||||||||
| Selling, General & Admin... | 438,347.00 | 474,168.00 | 663,956.00 | 1,136,109.00 | 2,000,035.00 | 2,544,937.00 | 4,184,193.00 | ||||||||||||
| Selling & Marketing Exp... | 1,620.00 | 337,255.00 | 34,116.00 | 887,071.00 | 130,362.00 | 194,821.00 | 238,264.00 | ||||||||||||
| Depreciation and Amortiz... | 14,040.00 | 3,552.00 | 7,727.00 | 7,727.00 | 20,607.00 | 113,615.00 | 360,162.00 | ||||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 700,032.00 | 2,790,542.00 | 0.00 | ||||||||||||
| Total Operating Expenses | 690,248.00 | 679,553.00 | 1,130,729.00 | 1,800,222.00 | 4,104,162.00 | 7,898,410.00 | 8,545,284.00 | ||||||||||||
| Cost and Exponses | 704,288.00 | 683,105.00 | 1,138,456.00 | 1,800,222.00 | 4,104,162.00 | 7,898,410.00 | 8,545,284.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-704,290.00
+0% |
-683,100.00
-3% |
-1,138,460.00
+67% |
-1,800,220.00
+58% |
-4,104,162.00
+128% |
-7,898,410.00
+92% |
-5,447,185.00
-31% |
||||||||||||
| Operating Income Ratio | (-2.91%) | (-2.65%) | (-2.58%) | (-6.54%) | (-5.71%) | (-2.77%) | (-1.76%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 1,134.00 | 1,710.00 | 504.00 | 252.00 | 18,637.00 | 62,152.00 | 51,392.00 | ||||||||||||
| Interest Expenses | 5,632.00 | 5,096.00 | 0.00 | 0.00 | 0.00 | 16,039.00 | 99,927.00 | ||||||||||||
| Total Other Income/Exp... | -4,496.00 | -265,181.00 | -349,709.00 | -866,050.00 | 718,668.00 | 2,836,655.00 | -3,999,713.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -690,250.00 | -677,843.00 | -1,030,615.00 | -1,799,970.00 | -4,064,917.00 | -7,722,643.00 | -5,666,812.00 | ||||||||||||
| EBITDA ratio | (-2.85%) | (-2.63%) | (-2.56%) | (-6.54%) | (-5.68%) | (-2.73%) | (-1.83%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -708,786.00 | -686,491.00 | -1,038,342.00 | -1,799,970.00 | -3,385,493.00 | -5,061,755.00 | -9,446,898.00 | ||||||||||||
| Income Before Tax Ratio | (-2.93%) | (-2.66%) | (-2.35%) | (-6.54%) | (-4.71%) | (-1.77%) | (-3.05%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -241,154.00 | -256,533.00 | -341,982.00 | -275,000.00 | -18,637.00 | -46,113.00 | -3,046,707.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -467,632.00
+0% |
-429,957.00
-8% |
-696,360.00
+62% |
-1,524,970.00
+119% |
-3,385,493.00
+122% |
-5,061,755.00
+50% |
-6,400,191.00
+26% |
||||||||||||
| Net Income Ratio | (-1.93%) | (-1.66%) | (-1.58%) | (-5.54%) | (-4.71%) | (-1.77%) | (-2.07%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | -0.03 | ||||||||||||
| Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | -0.03 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 215,135,633.00 | 215,135,633.00 | 215,135,633.00 | 215,135,633.00 | 204,285,974.00 | 210,902,747.00 | 246,161,192.00 | ||||||||||||
| Diluted Share Outstanding | 215,135,633.00 | 215,135,633.00 | 215,135,633.00 | 215,135,633.00 | 204,285,974.00 | 210,902,747.00 | 246,225,497.00 | ||||||||||||